FDA pans Merck's new pain pill

Apr 13, 2007

The U.S. Food and Drug Administration has rejected Merck's bid to sell the pain medication Arcoxia in the United States.

The New York Times says Arcoxia is a sister to Vioxx, which Merck pulled from the market in 2004 after a study showed it increased the risks of heart attacks and strokes.

Arcoxia, currently sold in 63 countries, caused nearly three times as many heart attacks, strokes and deaths as naproxen, which is sold as Aleve, and is about just as effective at reducing pain in arthritis patients. Patients taking Arcoxia also suffered increased blood pressure, the newspaper said.

"What you're talking about is a potential public health disaster," Dr. David Graham, an FDA safety officer, told the panel.

The company said it was "disappointed" in the FDA's rejection.

"We continue to believe that Arcoxia has the potential to become a valuable treatment option for many Americans suffering from osteoarthritis," Merck Research Laboratories President Peter Kim said in a release.

Merck will continue to sell the drug outside the United States, the newspaper said.

Copyright 2007 by United Press International

Explore further: Rapamune approved for rare lung disease

Related Stories

Biosensor may improve clinical diagnosis of influenza A

8 minutes ago

Sensors based on special sound waves known as surface acoustic waves (SAWs) are capable of detecting tiny amounts of antigens of Influenza A viruses. Developed by A*STAR researchers, the biosensors have the ...

Scientist provides new fluid dynamics insights

9 minutes ago

New calculations by a theoretical astrophysicist at The University of Alabama in Huntsville (UAH) provide tools that open a door to exploring the history of events in astrophysical flows and in plasma fusion ...

Protecting food, energy and livelihoods in Punjab

15 minutes ago

The state of Punjab spearheaded the Green Revolution that has transformed Indian agriculture. Encouraged by price guarantees, expanded irrigation and the introduction of high-yielding crop varieties, Punjabi ...

Faster evolution not responsible for tropical biodiversity

16 minutes ago

It's been known for more than 150 years that the tropics are home to far greater numbers of animal and plant species than the planet's temperate regions. But despite decades of study, the causes of this striking ...

Recommended for you

Rapamune approved for rare lung disease

19 hours ago

(HealthDay)—Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat a rare, progressive lung disease that mostly affects women of childbearing age.

FDA warns of complications from facial fillers

20 hours ago

(HealthDay)—Soft tissue fillers used in cosmetic procedures can accidentally be injected into blood vessels in the face and cause serious harm, the U.S. Food and Drug Administration warns.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.